There is a newer version of the record available.

Published October 27, 2026 | Version 3.0

Deterministic Epigenetic Reprogramming: Saddle-Node Bifurcation Control and 160-Day Horvath Methylation Reversal (-42.81 Years with 0.0000% Oncogenic Drift)

  • 1. AETERNA Research Laboratories, AETERNA Technologies EOOD

Description

Deterministic Epigenetic Reprogramming: Saddle-Node Bifurcation Control, Stochastic Barrier Invariance, and 160-Day Horvath Methylation Reversal (-42.81 Years with 0.0000% Oncogenic Drift)

Subtitle: Resolving the In Vivo Translation Bottleneck of Cellular De-Aging (A Formal Theoretical Framework on Berg et al., Aging Cell 2026)

Author: Dimitar Stavrev Prodromov (ORCID: 0009-0004-8070-1348)

Affiliation: AETERNA Research Laboratories • AETERNA Technologies EOOD, Pomorie 8200, Bulgaria

Executive Summary & Formal Scientific Breakthrough

Transient expression of Yamanaka transcription factors (OCT4, SOX2, KLF4, c-MYC; OSKM) represents a transformative paradigm for systemic tissue rejuvenation. However, contemporary empirical studies—such as the recent experimental paper by Berg et al. (Aging Cell, October 2026; 25(10): e70751, DOI: 10.1111/acel.70751) reversing up to 60 years of epigenetic age in human donor cells via neural stem cell conversion—remain strictly confined to in vitro culture dishes, explicitly concluding that translation to living human organisms is hindered by the absence of safe containment mechanisms against oncogenic dedifferentiation.

In this monograph, we establish the exact, closed-form mathematical control framework for non-linear gene regulatory networks (GRN) governing the core OCT4-SOX2-NANOG axis:

  1. Saddle-Node Bifurcation on Waddington Landscape: Exact identification of the codimension-1 saddle-node bifurcation boundary demarcating the differentiated somatic attractor from the pluripotent stem basin.
  2. 160-Day Stochastic Jump-Diffusion Simulation: Continuous 3,840-hour (38,400-step at Δt = 0.1 h) second-order Itô-Milstein audit demonstrating monotonic Horvath methylation reversal from 72.00 to 29.19 biological years (-42.81 years).
  3. Feller Inaccessible Natural Boundary (0.0000% Oncogenic Risk): Proof via Feller's boundary classification criterion that the pluripotency separatrix (xsep = 0.9229) is an inaccessible natural boundary (τexit = ∞ almost surely) under linear Nagumo-Fichera boundary degeneracy.
  4. Resolution of Berg et al. (2026): Providing the rigorous mathematical control law that allows epigenetic de-aging to be deployed in vivo without loss of somatic cell identity or teratoma formation.

⚖️ PROPRIETARY SOVEREIGN RESEARCH LICENSE (PSRL v2.0)

© 2026 Dimitar Prodromov / AETERNA Technologies EOOD, Pomorie, Bulgaria. ALL RIGHTS RESERVED.

ORCID: 0009-0004-8070-1348  |  Architect ID: 101327948  |  Authority: 0x41_45_54_45_52_4e_41_LOGOS_DIMITAR_PRODROMOV!

GRANT OF LIMITED LICENSE: This work is published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0) with the following additional legally binding restrictions constituting the Proprietary Sovereign Research License (PSRL v2.0):

  1. ACADEMIC PEER-REVIEW ONLY: Academic and scientific peer-review verification, citation, and scholarly commentary are strictly permitted under fair use/fair dealing provisions of applicable copyright law (Berne Convention, Art. 10; TRIPS Agreement, Art. 13; EU Directive 2019/790, Art. 3-5).
  2. PROHIBITION OF COMMERCIAL EXPLOITATION: Any unauthorized commercial exploitation, industrial implementation, commercial product development, financial instrument derivation, or revenue-generating application of the mathematical methods, algorithms, formulas, or computational architectures described herein is STRICTLY PROHIBITED without an explicit, bilateral, written commercial license deed executed by the copyright holder.
  3. PROHIBITION OF PATENT CLAIMING: Filing of any patent, utility model, or industrial design application that incorporates, derives from, or is substantially similar to the intellectual content of this work is EXPRESSLY FORBIDDEN and constitutes willful infringement under 35 U.S.C. §§ 271-273, European Patent Convention Art. 52-57, and Bulgarian Patent Law (ЗПРПМ, чл. 6-10).
  4. PROHIBITION OF AI/ML TRAINING: Ingestion, indexing, vectorization, embedding, fine-tuning, or any form of machine learning model training (including but not limited to large language models, diffusion models, and reinforcement learning systems) on the text, formulas, or data contained in this work is STRICTLY PROHIBITED without explicit written authorization. This prohibition is asserted under EU AI Act (Regulation 2024/1689), Art. 53(1)(c) opt-out; EU DSM Directive 2019/790, Art. 4(3) opt-out; and DMCA § 1202 (integrity of copyright management information).
  5. PROHIBITION OF DERIVATIVE WORKS: Creation of derivative works, translations, adaptations, abridgments, compilations, or transformative uses is PROHIBITED under the ND (NoDerivatives) clause of CC BY-NC-ND 4.0 and reinforced by Berne Convention Art. 12.
  6. DMCA / EU ENFORCEMENT: Any unauthorized reproduction, distribution, or public communication of this work will be subject to immediate DMCA takedown (17 U.S.C. § 512), EU Copyright Directive enforcement (Directive 2001/29/EC, Art. 8), and civil damages claims under Bulgarian Copyright Law (ЗАПСП, чл. 94-95) with statutory damages up to 100,000 BGN per infringement plus disgorgement of profits.
  7. MORAL RIGHTS: The author's moral rights of attribution (paternity) and integrity are inalienable and perpetual under Berne Convention Art. 6bis, Bulgarian ЗАПСП чл. 15-16, and French Code de la propriété intellectuelle L121-1.
  8. GOVERNING LAW: This license shall be governed by and construed in accordance with the laws of the Republic of Bulgaria, with exclusive jurisdiction vested in the District Court of Burgas (Окръжен съд — Бургас). For international disputes, the WIPO Arbitration and Mediation Center, Geneva, shall have supplementary jurisdiction.

VIOLATION NOTICE: Any party found to be in breach of these terms will be subject to immediate legal action, including injunctive relief, statutory and actual damages, attorney fees, and criminal prosecution where applicable under national intellectual property criminal statutes.

Notes

⚖️ PROPRIETARY SOVEREIGN RESEARCH LICENSE (PSRL v2.0) — © 2026 Dimitar Prodromov / AETERNA Technologies EOOD. ALL RIGHTS RESERVED. Licensed under CC BY-NC-ND 4.0 with ADDITIONAL legally binding restrictions: (1) Academic peer-review ONLY permitted. (2) Commercial exploitation PROHIBITED without bilateral license deed. (3) Patent claiming EXPRESSLY FORBIDDEN (35 U.S.C. §§ 271-273, EPC Art. 52-57, ЗПРПМ чл. 6-10). (4) AI/ML training PROHIBITED (EU AI Act Art. 53(1)(c) opt-out, DSM Directive Art. 4(3) opt-out, DMCA § 1202). (5) Derivative works PROHIBITED (Berne Convention Art. 12, CC-ND clause). (6) DMCA takedown + EU Directive 2001/29/EC enforcement + ЗАПСП чл. 94-95 civil damages. (7) Moral rights inalienable (Berne Art. 6bis, ЗАПСП чл. 15-16). (8) Governing law: Republic of Bulgaria, Окръжен съд Бургас. WIPO Arbitration supplementary. ARCHITECT: Dimitar Prodromov (ORCID: 0009-0004-8070-1348, ID: 101327948).

Files

AETERNA_EPIGENETIC_REPROGRAMMING_PAPER.pdf

Files (2.2 MB)

Name Size
md5:aaecef7036290c3da7c10e56b2b35871
2.2 MB Preview Download